JP2022527334A5 - - Google Patents
Info
- Publication number
- JP2022527334A5 JP2022527334A5 JP2021558768A JP2021558768A JP2022527334A5 JP 2022527334 A5 JP2022527334 A5 JP 2022527334A5 JP 2021558768 A JP2021558768 A JP 2021558768A JP 2021558768 A JP2021558768 A JP 2021558768A JP 2022527334 A5 JP2022527334 A5 JP 2022527334A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025166226A JP2026031542A (ja) | 2019-04-02 | 2025-10-02 | 腫瘍を処置するための抗ｃｄ７３、抗ｐｄ－ｌ１抗体及び化学療法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962828177P | 2019-04-02 | 2019-04-02 | |
| US62/828,177 | 2019-04-02 | ||
| PCT/IB2020/053110 WO2020202038A1 (en) | 2019-04-02 | 2020-04-01 | Anti-cd73, anti-pd-l1 antibodies and chemotherapy for treating tumors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025166226A Division JP2026031542A (ja) | 2019-04-02 | 2025-10-02 | 腫瘍を処置するための抗ｃｄ７３、抗ｐｄ－ｌ１抗体及び化学療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022527334A JP2022527334A (ja) | 2022-06-01 |
| JPWO2020202038A5 JPWO2020202038A5 (https=) | 2023-11-08 |
| JP2022527334A5 true JP2022527334A5 (https=) | 2023-11-08 |
Family
ID=72663659
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021558768A Pending JP2022527334A (ja) | 2019-04-02 | 2020-04-01 | 腫瘍を処置するための抗ｃｄ７３、抗ｐｄ－ｌ１抗体及び化学療法 |
| JP2025166226A Pending JP2026031542A (ja) | 2019-04-02 | 2025-10-02 | 腫瘍を処置するための抗ｃｄ７３、抗ｐｄ－ｌ１抗体及び化学療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025166226A Pending JP2026031542A (ja) | 2019-04-02 | 2025-10-02 | 腫瘍を処置するための抗ｃｄ７３、抗ｐｄ－ｌ１抗体及び化学療法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200317803A1 (https=) |
| EP (1) | EP3947447A4 (https=) |
| JP (2) | JP2022527334A (https=) |
| KR (1) | KR20210148253A (https=) |
| CN (2) | CN113993890A (https=) |
| AU (2) | AU2020254100B9 (https=) |
| CA (1) | CA3134671A1 (https=) |
| EA (1) | EA202192587A1 (https=) |
| IL (1) | IL286504A (https=) |
| MA (1) | MA55558A (https=) |
| SG (1) | SG11202110694RA (https=) |
| TW (1) | TW202102545A (https=) |
| WO (1) | WO2020202038A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116209468A (zh) * | 2020-09-23 | 2023-06-02 | 免疫医疗有限责任公司 | 使用抗cd73和抗pd-l1抗体和化疗的治疗方法 |
| CN119173276A (zh) | 2022-04-13 | 2024-12-20 | 吉利德科学公司 | 用于治疗表达Trop-2的癌症的组合疗法 |
| WO2023227115A1 (en) * | 2022-05-26 | 2023-11-30 | I-Mab Biopharma Co., Ltd. | A method of treating solid tumor |
| EP4626552A1 (en) * | 2022-12-01 | 2025-10-08 | MedImmune Limited | Combination therapy for treatment of cancer comprising anti-pd-l1 and anti-cd73 antibodies |
| WO2025137640A1 (en) | 2023-12-22 | 2025-06-26 | Gilead Sciences, Inc. | Azaspiro wrn inhibitors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020032315A1 (en) | 1997-08-06 | 2002-03-14 | Manuel Baca | Anti-vegf antibodies |
| US6884879B1 (en) | 1997-04-07 | 2005-04-26 | Genentech, Inc. | Anti-VEGF antibodies |
| NZ628923A (en) | 2009-11-24 | 2016-02-26 | Medimmune Ltd | Targeted binding agents against b7-h1 |
| DK3218406T4 (da) * | 2014-11-10 | 2024-12-09 | Medimmune Ltd | Bindingsmolekyler, der er specifikke for cd73, og anvendelser deraf |
| KR20230038311A (ko) * | 2016-03-04 | 2023-03-17 | 브리스톨-마이어스 스큅 컴퍼니 | 항-cd73 항체와의 조합 요법 |
| FI3922279T3 (fi) * | 2016-08-30 | 2025-02-04 | Dana Farber Cancer Inst Inc | Lääkkeenantokoostumuksia ja niiden käyttötapoja |
| CN118307674A (zh) * | 2017-06-22 | 2024-07-09 | 诺华股份有限公司 | 针对cd73的抗体分子及其用途 |
-
2020
- 2020-04-01 US US16/837,477 patent/US20200317803A1/en not_active Abandoned
- 2020-04-01 KR KR1020217035422A patent/KR20210148253A/ko active Pending
- 2020-04-01 JP JP2021558768A patent/JP2022527334A/ja active Pending
- 2020-04-01 WO PCT/IB2020/053110 patent/WO2020202038A1/en not_active Ceased
- 2020-04-01 CN CN202080039845.5A patent/CN113993890A/zh active Pending
- 2020-04-01 TW TW109111394A patent/TW202102545A/zh unknown
- 2020-04-01 EA EA202192587A patent/EA202192587A1/ru unknown
- 2020-04-01 CN CN202510064168.7A patent/CN119857140A/zh active Pending
- 2020-04-01 CA CA3134671A patent/CA3134671A1/en active Pending
- 2020-04-01 AU AU2020254100A patent/AU2020254100B9/en active Active
- 2020-04-01 MA MA055558A patent/MA55558A/fr unknown
- 2020-04-01 EP EP20783214.8A patent/EP3947447A4/en not_active Withdrawn
- 2020-04-01 SG SG11202110694RA patent/SG11202110694RA/en unknown
-
2021
- 2021-09-19 IL IL286504A patent/IL286504A/en unknown
-
2025
- 2025-01-06 AU AU2025200063A patent/AU2025200063A1/en active Pending
- 2025-10-02 JP JP2025166226A patent/JP2026031542A/ja active Pending